Claudia Peitzsch

@tu-dresden.de

Mass Cytometry Facility, Dresden University of Technology
Center for Regenerative Therapies Dresden (CRTD)

Claudia Peitzsch


                  Download Compact PDF  
https://researchid.co/claudia.peitzsch

RESEARCH, TEACHING, or OTHER INTERESTS

Cell Biology, Cancer Research, Molecular Medicine, Immunology
4037

Scholar Citations

28

Scholar h-index

35

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction
    K Lakshmi, A Jutrzenka-Trzebiatowski, L Loureiro, KEG Soto, K Peter, ...
    Journal of translational medicine 23 (1), 1399 , 2025
    2025
    Citations: 1
  • Epigenome profiling identifies H3K27me3 regulation of extracellular matrix composition in human corticogenesis
    N Ditzer, E Senoglu, A Kolodziejczyk, TM Schütze, A Nikolaidi, K Küster, ...
    Neuron 113 (18), 2927-2944. e10 , 2025
    2025
    Citations: 6
  • Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism
    I Gorodetska, V Lukiyanchuk, M Gawin, M Sliusar, A Linge, F Lohaus, ...
    Journal of Experimental & Clinical Cancer Research 44 (1), 105 , 2025
    2025
    Citations: 8
  • Epigenetic targeting to overcome radioresistance in head and neck cancer
    I Schniewind, MJ Besso, S Klicker, FM Schwarz, WW Hadiwikarta, ...
    Cancers 16 (4), 730 , 2024
    2024
    Citations: 11
  • Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy
    D Klusa, F Lohaus, A Franken, M Baumbach, M Cojoc, P Dowling, ...
    International Journal of Cancer 152 (12), 2639-2654 , 2023
    2023
    Citations: 25
  • Metabolic regulation of prostate cancer heterogeneity and plasticity
    C Peitzsch, I Gorodetska, D Klusa, Q Shi, TC Alves, K Pantel, ...
    Seminars in cancer biology 82, 94-119 , 2022
    2022
    Citations: 59
  • Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
    L Donix, HHH Erb, C Peitzsch, A Dubrovska, M Pfeifer, C Thomas, ...
    Journal of Cancer Research and Clinical Oncology 148 (6), 1313-1324 , 2022
    2022
    Citations: 2
  • Plasticity within aldehyde dehydrogenase–positive cells determines prostate cancer radiosensitivity
    FM Schwarz, I Schniewind, MJ Besso, S Lange, A Linge, SG Patil, S Löck, ...
    Molecular cancer research 20 (5), 794-809 , 2022
    2022
    Citations: 19
  • Efficient DNA repair mitigates replication stress resulting in less immunogenic cytosolic DNA in radioresistant breast cancer stem cells
    F Meyer, AM Engel, AK Krause, T Wagner, L Poole, A Dubrovska, ...
    Frontiers in Immunology 13, 765284 , 2022
    2022
    Citations: 22
  • Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity
    I Schniewind, WW Hadiwikarta, J Grajek, J Poleszczuk, S Richter, ...
    Cell Reports 38 (8) , 2022
    2022
    Citations: 28
  • High‐Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance
    A Wursthorn, C Schwager, I Kurth, C Peitzsch, C Herold‐Mende, J Debus, ...
    International journal of cancer 150 (4), 663-677 , 2022
    2022
    Citations: 7
  • GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
    A Mukha, U Kahya, A Linge, O Chen, S Löck, V Lukiyanchuk, S Richter, ...
    Theranostics 11 (16), 7844 , 2021
    2021
    Citations: 166
  • Tyrosine kinase c-MET as therapeutic target for radiosensitization of head and neck squamous cell carcinomas
    L Luettich, MJ Besso, S Heiden, L Koi, M Baumann, M Krause, ...
    Cancers 13 (8), 1865 , 2021
    2021
    Citations: 22
  • Metastatic spread in prostate cancer patients influencing radiotherapy response
    D Klusa, F Lohaus, G Furesi, M Rauner, M Benešová, M Krause, I Kurth, ...
    Frontiers in oncology 10, 627379 , 2021
    2021
    Citations: 60
  • The role of lncRNAs TAPIR-1 and-2 as diagnostic markers and potential therapeutic targets in prostate cancer
    M Friedrich, K Wiedemann, K Reiche, SH Puppel, G Pfeifer, I Zipfel, ...
    Cancers 12 (5), 1122 , 2020
    2020
    Citations: 29
  • L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population
    N Terraneo, F Jacob, C Peitzsch, A Dubrovska, C Krudewig, YL Huang, ...
    Cancers 12 (1), 217 , 2020
    2020
    Citations: 38
  • BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype
    I Gorodetska, V Lukiyanchuk, C Peitzsch, I Kozeretska, A Dubrovska
    International journal of cancer 145 (11), 2974-2985 , 2019
    2019
    Citations: 77
  • Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse
    M Seifert, C Peitzsch, I Gorodetska, C Börner, B Klink, A Dubrovska
    PLoS computational biology 15 (11), e1007460 , 2019
    2019
    Citations: 50
  • When polymers meet carbon nanostructures: Expanding horizons in cancer therapy
    G Cirillo, C Peitzsch, O Vittorio, M Curcio, A Farfalla, F Voli, A Dubrovska, ...
    Future Medicinal Chemistry 11 (16), 2205-2231 , 2019
    2019
    Citations: 10
  • Cancer stem cells in radiation response: current views and future perspectives in radiation oncology
    C Peitzsch, I Kurth, N Ebert, A Dubrovska, M Baumann
    International journal of radiation biology 95 (7), 900-911 , 2019
    2019
    Citations: 42

MOST CITED SCHOLAR PUBLICATIONS

  • Cancer stem cells: The root of tumor recurrence and metastases
    C Peitzsch, A Tyutyunnykova, K Pantel, A Dubrovska
    Seminars in cancer biology 44, 10-24 , 2017
    2017
    Citations: 441
  • Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
    M Cojoc, C Peitzsch, F Trautmann, L Polishchuk, GD Telegeev, ...
    OncoTargets and therapy, 1347-1361 , 2013
    2013
    Citations: 356
  • CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
    M Augsten, C Hägglöf, E Olsson, C Stolz, P Tsagozis, T Levchenko, ...
    Proceedings of the National Academy of Sciences 106 (9), 3414-3419 , 2009
    2009
    Citations: 312
  • Aldehyde dehydrogenase is regulated by β-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells
    M Cojoc, C Peitzsch, I Kurth, F Trautmann, LA Kunz-Schughart, ...
    Cancer research 75 (7), 1482-1494 , 2015
    2015
    Citations: 293
  • Discovery of the cancer stem cell related determinants of radioresistance
    C Peitzsch, I Kurth, L Kunz-Schughart, M Baumann, A Dubrovska
    Radiotherapy and Oncology 108 (3), 378-387 , 2013
    2013
    Citations: 245
  • Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues
    VM Renoux, A Zriwil, C Peitzsch, J Michaëlsson, D Friberg, S Soneji, ...
    Immunity 43 (2), 394-407 , 2015
    2015
    Citations: 207
  • Cancer biomarker discovery: current status and future perspectives
    K Mäbert, M Cojoc, C Peitzsch, I Kurth, S Souchelnytskyi, A Dubrovska
    International journal of radiation biology 90 (8), 659-677 , 2014
    2014
    Citations: 205
  • GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
    A Mukha, U Kahya, A Linge, O Chen, S Löck, V Lukiyanchuk, S Richter, ...
    Theranostics 11 (16), 7844 , 2021
    2021
    Citations: 166
  • Hypoxia as a biomarker for radioresistant cancer stem cells
    C Peitzsch, R Perrin, RP Hill, A Dubrovska, I Kurth
    International journal of radiation biology 90 (8), 636-652 , 2014
    2014
    Citations: 166
  • Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
    I Kurth, L Hein, K Mäbert, C Peitzsch, L Koi, M Cojoc, L Kunz-Schughart, ...
    Oncotarget 6 (33), 34494 , 2015
    2015
    Citations: 135
  • “Radiobiology of Proton Therapy”: Results of an international expert workshop
    A Lühr, C von Neubeck, J Pawelke, A Seidlitz, C Peitzsch, SM Bentzen, ...
    Radiotherapy and Oncology 128 (1), 56-67 , 2018
    2018
    Citations: 130
  • Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis
    C Stolz, G Hess, PS Hähnel, F Grabellus, S Hoffarth, KW Schmid, ...
    Blood, The Journal of the American Society of Hematology 112 (8), 3312-3321 , 2008
    2008
    Citations: 123
  • Cancer stem cells in head and neck squamous cell carcinoma: identification, characterization and clinical implications
    C Peitzsch, J Nathansen, SI Schniewind, F Schwarz, A Dubrovska
    Cancers 11 (5), 616 , 2019
    2019
    Citations: 120
  • Nanoparticles for radiooncology: Mission, vision, challenges
    LA Kunz-Schughart, A Dubrovska, C Peitzsch, A Ewe, A Aigner, ...
    Biomaterials 120, 155-184 , 2017
    2017
    Citations: 119
  • CXCR4 as biomarker for radioresistant cancer stem cells
    F Trautmann, M Cojoc, I Kurth, N Melin, LC Bouchez, A Dubrovska, ...
    International journal of radiation biology 90 (8), 687-699 , 2014
    2014
    Citations: 110
  • An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells
    C Peitzsch, M Cojoc, L Hein, I Kurth, K Mäbert, F Trautmann, B Klink, ...
    Cancer research 76 (9), 2637-2651 , 2016
    2016
    Citations: 104
  • The CD98 heavy chain is a marker and regulator of head and neck squamous cell carcinoma radiosensitivity
    D Digomann, I Kurth, A Tyutyunnykova, O Chen, S Löck, I Gorodetska, ...
    Clinical Cancer Research 25 (10), 3152-3163 , 2019
    2019
    Citations: 86
  • BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype
    I Gorodetska, V Lukiyanchuk, C Peitzsch, I Kozeretska, A Dubrovska
    International journal of cancer 145 (11), 2974-2985 , 2019
    2019
    Citations: 77
  • Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention
    C Stolz, M Schuler
    Leukemia & lymphoma 50 (6), 873-885 , 2009
    2009
    Citations: 77
  • Metastatic spread in prostate cancer patients influencing radiotherapy response
    D Klusa, F Lohaus, G Furesi, M Rauner, M Benešová, M Krause, I Kurth, ...
    Frontiers in oncology 10, 627379 , 2021
    2021
    Citations: 60